These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24258305)

  • 41. Fibroblast growth factor 23 in acute burn patients: Novel insights from an intact-form assay.
    Rousseau AF; Souberbielle JC; Delanaye P; Damas P; Cavalier E
    Burns; 2016 Aug; 42(5):1082-1087. PubMed ID: 27215149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibroblast Growth Factor 23 Concentrations Reflect Sex Differences in Mineral Metabolism and Growth in Early Infancy.
    Holmlund-Suila E; Viljakainen H; Ljunggren Ö; Hytinantti T; Andersson S; Mäkitie O
    Horm Res Paediatr; 2016; 85(4):232-41. PubMed ID: 26943634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients.
    Honda H; Michihata T; Shishido K; Takahashi K; Takahashi G; Hosaka N; Ikeda M; Sanada D; Shibata T
    PLoS One; 2017; 12(5):e0176984. PubMed ID: 28475601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of vitamin D supplementation on circulating fibroblast growth factor-23 concentration in adults with prediabetes.
    Ceglia L; Pittas AG; Dawson-Hughes B
    Aging Clin Exp Res; 2023 Mar; 35(3):525-530. PubMed ID: 36631721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
    Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
    J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of vitamin D replacement therapy in serum FGF23 concentration in children with myelomeningocele compared with healthy children - a preliminary study.
    Bagińska J; Liszewska A; Korzeniecka-Kozerska A
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1259-1264. PubMed ID: 31465293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polyostotic osteolysis and hypophosphatemic rickets with elevated serum fibroblast growth factor 23: A case report.
    Sato T; Muroya K; Asakura Y; Yachie A; Nishimura G; Aida N; Machida J; Tanaka Y; Hasegawa T; Adachi M
    Am J Med Genet A; 2015 Oct; 167A(10):2430-4. PubMed ID: 26059403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of vitamin D2 and vitamin D3 on intestinal calcium absorption in Nigerian children with rickets.
    Thacher TD; Obadofin MO; O'Brien KO; Abrams SA
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3314-21. PubMed ID: 19567516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort.
    Kumar J; McDermott K; Abraham AG; Friedman LA; Johnson VL; Kaskel FJ; Furth SL; Warady BA; Portale AA; Melamed ML
    Pediatr Nephrol; 2016 Jan; 31(1):121-9. PubMed ID: 26307635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A PAI-1 antagonist ameliorates hypophosphatemia in the Hyp vitamin D-resistant rickets model mouse.
    Qian C; Ito N; Tsuji K; Sato S; Kikuchi K; Yoshii T; Miyata T; Asou Y
    FEBS Open Bio; 2024 Feb; 14(2):290-299. PubMed ID: 38050660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic rescue of glycosylation-deficient Fgf23 in the Galnt3 knockout mouse.
    Ichikawa S; Gray AK; Padgett LR; Allen MR; Clinkenbeard EL; Sarpa NM; White KE; Econs MJ
    Endocrinology; 2014 Oct; 155(10):3891-8. PubMed ID: 25051439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.
    Liu ES; Martins JS; Raimann A; Chae BT; Brooks DJ; Jorgetti V; Bouxsein ML; Demay MB
    J Bone Miner Res; 2016 May; 31(5):929-39. PubMed ID: 26751835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of burosumab on intact and C-terminal FGF23 measurements.
    Ashrafzadeh-Kian SL; Ito N; Srivastava T; Garg U; Kato H; Algeciras-Schimnich A; Bornhorst JA
    Clin Endocrinol (Oxf); 2023 Aug; 99(2):152-157. PubMed ID: 36263608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteocytes and the pathogenesis of hypophosphatemic rickets.
    Yamazaki M; Michigami T
    Front Endocrinol (Lausanne); 2022; 13():1005189. PubMed ID: 36246908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic and clinical profile of patients with hypophosphatemic rickets.
    Marik B; Bagga A; Sinha A; Khandelwal P; Hari P; Sharma A
    Eur J Med Genet; 2022 Aug; 65(8):104540. PubMed ID: 35738466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations.
    Ichikawa S; Guigonis V; Imel EA; Courouble M; Heissat S; Henley JD; Sorenson AH; Petit B; Lienhardt A; Econs MJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1943-7. PubMed ID: 17311862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosis.
    Loid P; Hauta-Alus H; Mäkitie O; Magnusson P; Mäkitie RE
    Front Endocrinol (Lausanne); 2022; 13():954730. PubMed ID: 36157448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses.
    Block GA; Pergola PE; Fishbane S; Martins JG; LeWinter RD; Uhlig K; Neylan JF; Chertow GM
    Nephrol Dial Transplant; 2019 Jul; 34(7):1115-1124. PubMed ID: 30380116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.